SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001663577-23-000418
Filing Date
2023-08-15
Accepted
2023-08-15 14:45:21
Documents
39
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 abti10q_063023.htm   iXBRL 10-Q 513031
2 ex31_1.htm EX-31.1 9051
3 ex31_2.htm EX-31.2 9051
4 ex32_1.htm EX-32.1 5773
10 GRAPHIC image_001.jpg GRAPHIC 2736
  Complete submission text file 0001663577-23-000418.txt   2470230

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE abti-20230630.xsd EX-101.SCH 22002
6 XBRL CALCULATION FILE abti-20230630_cal.xml EX-101.CAL 31661
7 XBRL DEFINITION FILE abti-20230630_def.xml EX-101.DEF 55562
8 XBRL LABEL FILE abti-20230630_lab.xml EX-101.LAB 167305
9 XBRL PRESENTATION FILE abti-20230630_pre.xml EX-101.PRE 130825
33 EXTRACTED XBRL INSTANCE DOCUMENT abti10q_063023_htm.xml XML 234874
Mailing Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR
Business Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR 44 151 601 9477
ALTEROLA BIOTECH INC. (Filer) CIK: 0001442999 (see all company filings)

IRS No.: 821317032 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 333-156091 | Film No.: 231174496
SIC: 2833 Medicinal Chemicals & Botanical Products